Novel Compounds as NIK Inhibitors for Treating Autoimmune Diseases

Abstract Provided herein are novel compounds as NIK inhibitors, pharmaceutical compositions, use of such compounds in treating autoimmune diseases, and processes for preparing such compounds.

Authors

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2026-10-22
DOI
https://doi.org/10.1021/acsmedchemlett.6c00558
Primary Topic
NF-κB Signaling Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Compounds as NIK Inhibitors for Treating Autoimmune Diseases

Ram W. Sabnis
ACS Medicinal Chemistry Letters
NF-κB Signaling Pathways
article

Novel Compounds as NIK Inhibitors for Treating Autoimmune Diseases

Ram W. Sabnis
article en

Abstract

Abstract Provided herein are novel compounds as NIK inhibitors, pharmaceutical compositions, use of such compounds in treating autoimmune diseases, and processes for preparing such compounds.

ACS Medicinal Chemistry Letters
Openalex Percentile: Top 19%
NF-κB Signaling Pathways
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Novel Compounds as NIK Inhibitors for Treating Autoimmune Diseases — Ram W. Sabnis · ACS Medicinal Chemistry Letters (2026) | TGRS Research Map | TGRS